Table 1.

A comparison of general clinical data and biochemical markers between groups with good and poor prognosis

Observational indicator	Good prognosis group (n = 151)	Poor prognosis group (n = 40)	t/X2	P
Age (years, mean ± s)	59 ± 9.7	65 ± 14	-2.483	0.017
Gender [n (%)]			0.624	0.430
Male	103(68.2%)	24(60.0%)
Female	48(31.8%)	16 (40.0%)
History of high blood pressure [n (%)]	111(73.5%)	34(85.0%)	1.698	0.193
History of diabetes [n (%)]	55(36.4%)	21(52.5%)	2.773	0.096
Previous coronary intervention [n (%)]	45(29.8%)	21(52.5%)	6.236	0.013
Previous myocardial infarction [n (%)]	30(19.9%)	10(25.0%)	0.241	0.624
Smoking history [n (%)]	98(64.9%)	23(57.5%)	0.461	0.497
Diagnosis [n (%)]			7.063	0.070
Acute non-ST elevation myocardial infarction	22(14.6%)	7(17.5%)
Acute ST elevation myocardial infarction	30(19.9%)	1(2.5%)
Stable angina	20(13.2%)	7(17.5%)
Unstable angina	79(52.3%)	25(62.5%)
TSH (uIU/ml, mean ± s)	2.8 ± 2.6	5.3 ± 15	− 1.053	0.299
FT3(pmol/L, mean ± s)	4.4 ± 0.72	4. 1 ± 0.90	2.013	0.049
FT4(pmol/L, mean ± s)	16 ± 2.5	15 ± 3.0	0.540	0.592
Platelet count (× 109/L, mean ± s)	210 ± 52	220 ± 70	-0.646	0.521
Fibrinogen (g/L, mean ± s)	3. 1 ± 0.90	3.2 ± 0.70	-0.721	0.473
Uric acid (µmol/L, mean ± s)	340 ± 85	330 ± 91	0.290	0.773
Triglycerides (mmol/L, mean ± s)	1.9 ± 1.2	1.8 ± 0.78	1.007	0.317
Total cholesterol (mmol/L, mean ± s)	4. 1 ± 1. 1	4. 1 ± 1.3	0.040	0.969
High-density lipoprotein (mmol/L, mean ± s)	1.0 ± 0.29	1.0 ± 0.20	-0.458	0.648
Low-density lipoprotein (mmol/L, mean ± s)	2.5 ± 0.95	2.5 ± 0.97	0.329	0.743
Cardiac injury markers (ng/L, mean ± s)	320 ± 810	200 ± 360	1.314	0.191
N-terminal pro b-type natriuretic peptide (pg/ml, mean ± s)	330 ± 570	900 ± 1400	-2.476	0.017
Homocysteine (µmol/L, mean ± s)	16 ± 10	16 ± 8.0	0.067	0.947
Glycated hemoglobin (%, mean ± s)	2.9 ± 4.0	3.9 ± 3.7	− 1.468	0.147
Ejection fraction (%, mean ± s)	62 ± 7.4	61 ± 7.8	0.743	0.460
Gensini score (mean ± s)	40 ± 25	44 ± 22	-0.986	0.032